How to Read the Funding Section of a Dementia Paper

Funding sources shape dementia research findings more than most readers realize—here's how to spot bias in research papers.

Funding sources shape dementia research findings more than most readers realize—here's how to spot bias in research papers.

Pharmaceutical companies fund three-quarters of major Alzheimer's drug trials, and evidence shows industry-funded studies are 32 times more likely to report favorable results.

Regular exercise rebuilds your brain's protective architecture by growing new neurons and strengthening neural connections over years.

Detecting Alzheimer's pathology before symptoms appear raises hard questions about diagnosis, consent, risk, and who deserves access.

Many common conditions mimic Alzheimer's symptoms—but online symptom checkers can't tell the difference.

A normal MoCA score doesn't rule out cognitive decline, and an abnormal score isn't a diagnosis—here's why the test's limitations matter.

Alzheimer's damages the brain's decision-making and planning center long before memory loss becomes severe, leaving people unable to organize even simple daily tasks.

Stress makes you forgetful; dementia erases memories permanently. Here's how to tell the difference.

Dementia nonprofits can't fund patient care through grant writing alone. Fundraising parties build donor commitment in ways that direct mail and email never will.

Kickoff events introduce participants to the walk's mission, logistics, and volunteer roles weeks before the actual fundraising day.